Panaxynol mitigates chemotherapy-induced intestinal mucositis by improving the colonic microenvironment in murine models.

Key Points

• To evaluate the efficacy of panaxynol in alleviating chemotherapy-induced intestinal mucositis in murine models.
• Utilized murine models to assess the effects of panaxynol on chemotherapy-induced intestinal mucositis.
• Analyzed the colonic microenvironment and its response to 5FU treatment.
• Panaxynol treatment improved the colonic microenvironment in mice treated with 5FU.
• Reduction in intestinal mucositis symptoms was observed with panaxynol administration.